Cargando…

Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia

BACKGROUND: Preeclampsia is a dangerous cardiovascular disorder of pregnancy that leads to an increased risk of future cardiovascular and metabolic disorders. Much of the pathogenesis and mechanisms involved in cardiac health in preeclampsia are unknown. A novel anti-angiogenic protein, FKBPL, is em...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Claire, Sesperez, Kimberly, Chhor, Michael, Ghorbanpour, Sahar, Rennie, Claire, Ming, Clara Liu Chung, Evenhuis, Chris, Nikolic, Valentina, Orlic, Natasa Karadzov, Mikovic, Zeljko, Stefanovic, Milan, Cakic, Zoran, McGrath, Kristine, Gentile, Carmine, Bubb, Kristen, McClements, Lana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056582/
https://www.ncbi.nlm.nih.gov/pubmed/33879252
http://dx.doi.org/10.1186/s13293-021-00376-1
_version_ 1783680677182439424
author Richards, Claire
Sesperez, Kimberly
Chhor, Michael
Ghorbanpour, Sahar
Rennie, Claire
Ming, Clara Liu Chung
Evenhuis, Chris
Nikolic, Valentina
Orlic, Natasa Karadzov
Mikovic, Zeljko
Stefanovic, Milan
Cakic, Zoran
McGrath, Kristine
Gentile, Carmine
Bubb, Kristen
McClements, Lana
author_facet Richards, Claire
Sesperez, Kimberly
Chhor, Michael
Ghorbanpour, Sahar
Rennie, Claire
Ming, Clara Liu Chung
Evenhuis, Chris
Nikolic, Valentina
Orlic, Natasa Karadzov
Mikovic, Zeljko
Stefanovic, Milan
Cakic, Zoran
McGrath, Kristine
Gentile, Carmine
Bubb, Kristen
McClements, Lana
author_sort Richards, Claire
collection PubMed
description BACKGROUND: Preeclampsia is a dangerous cardiovascular disorder of pregnancy that leads to an increased risk of future cardiovascular and metabolic disorders. Much of the pathogenesis and mechanisms involved in cardiac health in preeclampsia are unknown. A novel anti-angiogenic protein, FKBPL, is emerging as having a potential role in both preeclampsia and cardiovascular disease (CVD). Therefore, in this study we aimed to characterise cardiac health and FKBPL regulation in the rat reduced uterine perfusion pressure (RUPP) and a 3D cardiac spheroid model of preeclampsia. METHODS: The RUPP model was induced in pregnant rats and histological analysis performed on the heart, kidney, liver and placenta (n ≥ 6). Picrosirius red staining was performed to quantify collagen I and III deposition in rat hearts, placentae and livers as an indicator of fibrosis. RT-qPCR was used to determine changes in Fkbpl, Icam1, Vcam1, Flt1 and Vegfa mRNA in hearts and/or placentae and ELISA to evaluate cardiac brain natriuretic peptide (BNP45) and FKBPL secretion. Immunofluorescent staining was also conducted to analyse the expression of cardiac FKBPL. Cardiac spheroids were generated using human cardiac fibroblasts and human coronary artery endothelial cells and treated with patient plasma from normotensive controls, early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE); n = 3. FKBPL and CD31 expression was quantified by immunofluorescent labelling. RESULTS: The RUPP procedure induced significant increases in blood pressure (p < 0.001), collagen deposition (p < 0.001) and cardiac BNP45 (p < 0.05). It also induced a significant increase in cardiac FKBPL mRNA (p < 0.05) and protein  expression  (p < 0.01). RUPP placentae also exhibited increased collagen deposition and decreased Flt1 mRNA expression (p < 0.05). RUPP kidneys revealed an increase in average glomerular size (p < 0.05). Cardiac spheroids showed a significant increase in FKBPL expression when treated with LOPE plasma (p < 0.05) and a trend towards increased FKBPL expression following treatment with EOPE plasma (p = 0.06). CONCLUSIONS: The rat RUPP model induced cardiac, renal and placental features reflective of preeclampsia. FKBPL was increased in the hearts of RUPP rats and cardiac spheroids treated with plasma from women with preeclampsia, perhaps reflective of restricted angiogenesis and inflammation in this disorder. Elucidation of these novel FKBPL mechanisms in cardiac health in preeclampsia could be key in preventing future CVD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13293-021-00376-1.
format Online
Article
Text
id pubmed-8056582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80565822021-04-20 Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia Richards, Claire Sesperez, Kimberly Chhor, Michael Ghorbanpour, Sahar Rennie, Claire Ming, Clara Liu Chung Evenhuis, Chris Nikolic, Valentina Orlic, Natasa Karadzov Mikovic, Zeljko Stefanovic, Milan Cakic, Zoran McGrath, Kristine Gentile, Carmine Bubb, Kristen McClements, Lana Biol Sex Differ Research BACKGROUND: Preeclampsia is a dangerous cardiovascular disorder of pregnancy that leads to an increased risk of future cardiovascular and metabolic disorders. Much of the pathogenesis and mechanisms involved in cardiac health in preeclampsia are unknown. A novel anti-angiogenic protein, FKBPL, is emerging as having a potential role in both preeclampsia and cardiovascular disease (CVD). Therefore, in this study we aimed to characterise cardiac health and FKBPL regulation in the rat reduced uterine perfusion pressure (RUPP) and a 3D cardiac spheroid model of preeclampsia. METHODS: The RUPP model was induced in pregnant rats and histological analysis performed on the heart, kidney, liver and placenta (n ≥ 6). Picrosirius red staining was performed to quantify collagen I and III deposition in rat hearts, placentae and livers as an indicator of fibrosis. RT-qPCR was used to determine changes in Fkbpl, Icam1, Vcam1, Flt1 and Vegfa mRNA in hearts and/or placentae and ELISA to evaluate cardiac brain natriuretic peptide (BNP45) and FKBPL secretion. Immunofluorescent staining was also conducted to analyse the expression of cardiac FKBPL. Cardiac spheroids were generated using human cardiac fibroblasts and human coronary artery endothelial cells and treated with patient plasma from normotensive controls, early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE); n = 3. FKBPL and CD31 expression was quantified by immunofluorescent labelling. RESULTS: The RUPP procedure induced significant increases in blood pressure (p < 0.001), collagen deposition (p < 0.001) and cardiac BNP45 (p < 0.05). It also induced a significant increase in cardiac FKBPL mRNA (p < 0.05) and protein  expression  (p < 0.01). RUPP placentae also exhibited increased collagen deposition and decreased Flt1 mRNA expression (p < 0.05). RUPP kidneys revealed an increase in average glomerular size (p < 0.05). Cardiac spheroids showed a significant increase in FKBPL expression when treated with LOPE plasma (p < 0.05) and a trend towards increased FKBPL expression following treatment with EOPE plasma (p = 0.06). CONCLUSIONS: The rat RUPP model induced cardiac, renal and placental features reflective of preeclampsia. FKBPL was increased in the hearts of RUPP rats and cardiac spheroids treated with plasma from women with preeclampsia, perhaps reflective of restricted angiogenesis and inflammation in this disorder. Elucidation of these novel FKBPL mechanisms in cardiac health in preeclampsia could be key in preventing future CVD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13293-021-00376-1. BioMed Central 2021-04-20 /pmc/articles/PMC8056582/ /pubmed/33879252 http://dx.doi.org/10.1186/s13293-021-00376-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Richards, Claire
Sesperez, Kimberly
Chhor, Michael
Ghorbanpour, Sahar
Rennie, Claire
Ming, Clara Liu Chung
Evenhuis, Chris
Nikolic, Valentina
Orlic, Natasa Karadzov
Mikovic, Zeljko
Stefanovic, Milan
Cakic, Zoran
McGrath, Kristine
Gentile, Carmine
Bubb, Kristen
McClements, Lana
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title_full Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title_fullStr Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title_full_unstemmed Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title_short Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
title_sort characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3d cardiac spheroid model, of preeclampsia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056582/
https://www.ncbi.nlm.nih.gov/pubmed/33879252
http://dx.doi.org/10.1186/s13293-021-00376-1
work_keys_str_mv AT richardsclaire characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT sesperezkimberly characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT chhormichael characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT ghorbanpoursahar characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT rennieclaire characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT mingclaraliuchung characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT evenhuischris characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT nikolicvalentina characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT orlicnatasakaradzov characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT mikoviczeljko characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT stefanovicmilan characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT cakiczoran characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT mcgrathkristine characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT gentilecarmine characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT bubbkristen characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia
AT mcclementslana characterisationofcardiachealthinthereduceduterineperfusionpressuremodelanda3dcardiacspheroidmodelofpreeclampsia